ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025
Relationship Between Fat-to-Muscle Ratio and Nonalcoholic Fatty Liver Disease in Middle-Aged and Older Adults with Type 2 Diabetes: Cross-Sectional Study.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association of a novel Fat-Muscle-BMI Index (FMBI) with NAFLD, liver fibrosis, and atherosclerotic cardiovascular disease risk: a cross-sectional study in 1,592 Chinese adults.BMC gastroenterology · 2026Article
- Gender-Specific Associations of Muscle Strength With Diabetic Retinopathy in Middle-Aged and Older Chinese Adults: A Cross-Sectional Study.International journal of endocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The fat-to-muscle mass ratio (FMR) is an innovative metric that integrates fat and muscle constituents. The aim of this study was to examine the efficacy of FMR in predicting non-alcoholic fatty liver disease (NAFLD) in individuals with T2DM. Methods: This cross-sectional study enrolled 307 hospitalized patients aged 50 years and older with T2DM. NAFLD was identified during ultrasound examination. Fat mass and muscle mass were quantified using dual-energy X-ray absorptiometry (DXA), with FMR calculated as fat mass (kg) divided by muscle mass (kg). Results: FMR was markedly elevated in the NAFLD patient group compared to the healthy control group (p<0.001). Sex-specific analysis demonstrated notable sex differences in the diagnostic efficacy of this indicator for fatty liver: the area under the curve (AUC) of the subject's work characteristics was significantly greater in females compared to males (0.860 vs 0.805), and the optimal threshold was also significantly elevated in females relative to males (0.563 vs 0.363). FMR was established as an independent predictor of fatty liver through multifactorial regression modeling, revealing a risk ratio of 28.171 (95% CI 7.008-113.248, p<0.001) in males, while the risk ratio for females was 3.259 (95% CI 1.221-8.700, p=0.018), indicating higher predictive value in males. Conclusions: FMR was significantly and independently linked to an increased risk of NAFLD in middle-aged and elderly individuals with T2DM, a discovery that underpins the rationale for enhancing targeted interventions and prognostic management for patients with diabetes mellitus and fatty liver disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.